GeodAIsics
GeodAIsics is a France-based DeepTech company that develops proprietary AI-powered clinical and biological decision-support software (BrainGML, OncoGML, BioGML, OtoGML, LAbyrInth) for hospitals, radiology centers, medical biology laboratories, medical-device manufacturers and CROs using its patented Generative Manifold Learning technology.
- Company typePrivate
- Founded2021
- HeadquartersLa Tronche, France
- Headcount1–10
- GTM typeB2B
- OfferingSoftware
What GeodAIsics does
GeodAIsics SAS is a French DeepTech company founded in 2021 and headquartered in La Tronche (Grenoble), France, that develops clinical and biological decision-support software powered by its proprietary Generative Manifold Learning (GML) AI technology. GML is a generative AI methodology based on variety analysis that operates on low volumes of unlabeled routine-care data, builds personalized digital twins per patient, and detects anomalies (including disease subtypes) at population and individual level. The product portfolio comprises five proprietary software lines — BrainGML (brain MRI, including DementIA / BrainGML-AD for early Alzheimer's detection and differential dementia diagnosis), OncoGML (cancer prognosis and treatment outcome prediction, with focus on elderly breast cancer patients), BioGML (blood-sample validation with personalized reference values for kidney and liver disease), OtoGML (inner-ear MRI analysis including Ménière's disease), and LAbyrInth (automatic inner-ear anomaly detection) — all built on the same algorithmic foundation.
The company operates a dual go-to-market: (1) proprietary software licensed to hospitals, radiology centers, and biology laboratories, with BrainGML/DementIA on the path to CE marking as a medical device; and (2) custom AI software development using GML for medical-device manufacturers, LIS/HIS middleware vendors, pharmaceutical companies, CROs, and veterinary clinics, exemplified by the embedded AI module within BYG4lab's Ynfectio software. A secondary revenue stream is paid professional training workshops (historically €300 per session, €50 for interns) that double as a relationship-building channel with radiologists, neurologists and ORL specialists. Distribution is primarily direct-sales driven in France with extensions into validation partnerships across French university hospitals (AP-HP, HCL, CHU Grenoble, CHU Brest, CHU Rouen, CHU Nice, Centre Léon Bérard) and one international academic link (University of Sydney), supplemented by congress presence (JFR 2022, SFNR 2023), Bayer-co-branded webinars, and strategic partnerships with HORIBA (sepsis detection, 2025) and Les Biologistes Indépendants (capital entry 2025).
GeodAIsics is privately held, has approximately 14 team members, and has raised €400,000 from 10 physician business angels in February 2023 as the only disclosed equity financing to date. The founding team combines three medical doctors (neuroradiology, oncogenetics, medical biology) with a PhD in AI as CSO, and the company holds two pending patents covering its core GML methodologies.
GeodAIsics firmographics
Firmographics- Name
- GeodAIsics
- Legal name
- Geodaisics
- Website
- https://geodaisics.com
- Company type
- Private
- Founded year
- 2021
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- GeodAIsics is a France-based DeepTech company that develops proprietary AI-powered clinical and biological decision-support software (BrainGML, OncoGML, BioGML, OtoGML, LAbyrInth) for hospitals, radiology centers, medical biology laboratories, medical-device manufacturers and CROs using its patented Generative Manifold Learning technology.
- Ownership category
- akta.pro rank
GeodAIsics industry classification
Industry- Product category
- Clinical Decision Support Software
- NAICS
- Scientific Research and Development Services (5417)
- SIC
- Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- SaMD – Imaging & Signal Analysis (AI/ML) (HLACANAG)
- akta.pro secondary industries
- Radiology AI, CAD & Advanced Visualization Software (HLAHABAJ), Digital & AI-Enabled Diagnostics (algorithmic interpretation, decision support tied to assays) (HLAAALAO)
Keywords
Where GeodAIsics is headquartered
LocationHeadquarters
- HQ city
- La Tronche
- HQ country
- France
- HQ region
- Europe
Offices1 record
Markets served
GeodAIsics business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Technology or R&D, Personnel, Marketing or Sales, Operations, Infrastructure
Revenue model
- Proprietary Software Licenses: GeodAIsics develops and licenses proprietary clinical decision support software products (BrainGML, OncoGML, BioGML, OtoGML) to healthcare institutions, hospitals, and medical professionals. These are sold as software licenses, likely on a subscription or one-time license basis, targeting CE marking for regulatory approval.
- Custom Software Development: GeodAIsics develops custom software solutions for specific client applications using the same patented GML technology. Target clients include biological testing system manufacturers, quality control manufacturers, middleware providers, LIS/HIS vendors, pharmaceutical companies, CROs, hospitals, veterinary clinics, and medical device manufacturers.
- Professional Training and Workshops: GeodAIsics offers paid professional training workshops for healthcare professionals (radiologists, neurologists, geriatricians) on AI applications in medical imaging. Training is offered at €300 per session (past workshops) and €50 for interns (upcoming), conducted in-person and remotely.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | One time/ perpetual license | Professional Training - Past Sessions |
| Unit Pricing | One time/ perpetual license | Upcoming Training (September 2025) |
| Subscription | Annual | BrainGML-AD Software License |
Go-to-market motion3 records
Distribution channels3 records
Marketing channels6 records
GeodAIsics product offering
Product offeringCore offering
GeodAIsics develops and licenses proprietary clinical decision support software for medical imaging and biological analysis, powered by its patented Generative Manifold Learning (GML) AI technology. Core products include BrainGML (brain MRI analysis for Alzheimer's, Parkinson's, FTD), OncoGML (cancer prognosis), BioGML (blood sample validation), OtoGML and LAbyrInth (inner ear anomaly detection), plus DementIA for dementia differentiation. The company also offers custom software development and paid training workshops for healthcare professionals.
Product overview
GeodAIsics offers a unified clinical decision support platform powered by proprietary Generative Manifold Learning (GML) AI technology. The core product portfolio includes BrainGML for brain MRI analysis, OncoGML for cancer prognosis, BioGML for biological sample validation, and OtoGML for inner ear imaging. All products share the same GML algorithmic foundation that creates patient digital twins for personalized medical analysis. The company also provides custom software development services using the same patented technology for specific customer applications in healthcare, laboratory, and medical device sectors.
Differentiator
Problem solved
Functional benefit
Brands
- BrainGML: MRI analysis software for detecting anatomical changes in the brain, particularly for neurodegenerative and psychiatric disorders such as Alzheimer's, Parkinson's, and FTD.
- BrainGML-AD
- OncoGML
- BioGML
- OtoGML
- LAbyrInth
- DementIA
Products and services
- BrainGML Sophisticated MRI analysis software for detecting anatomical brain changes. Creates personalized atlases for neurodegenerative and psychiatric disorders including Alzheimer's, Parkinson's, and frontotemporal dementia. Includes DementIA functionality and BrainGML-AD variant.
- OncoGML Clinical decision support system predicting prognosis and treatment outcomes for cancer patients. Provides tailored treatment strategies based on patient profiles, with focus on elderly breast cancer patients.
- BioGML Validates blood samples with personalized standards for enhanced disease detection. Develops atlases for kidney and liver disease identification. Used for quality control validation.
- OtoGML Enables clinicians with tools for personalized inner ear MRI analysis. Detects structural abnormalities in inner ear including cochlea, vestibule, and semicircular canals. Aids diagnosis of Ménière's disease and labyrinthine anomalies.
- LAbyrInth Automatic detector of morphological anomalies in inner ear. Creates digital twins of cochlea (hearing) and vestibule/semicircular canals (balance). Award-winning innovation for diagnosing Ménière's disease and hydrops.
- DementIA AI software for dementia detection and differentiation. Part of BrainGML suite, on the path to CE marking. Distinguishes Alzheimer's from frontotemporal dementia, Lewy body disease, and vascular dementia.
- Custom Software Development Custom software development services using patented GML technology for specific customer applications. Targets middleware, LIS/HIS, pharmaceuticals, CROs, hospitals, laboratories, and medical device manufacturers.
- Professional Training Workshops Paid in-person and remote training workshops for healthcare professionals on AI applications in neuroimaging and inner-ear imaging. Past sessions covered neuro-degenerative diseases, cochleo-vestibular disorders, and demyelinating diseases at €300 per session. Upcoming session (Sept 2025) on biological Alzheimer diagnosis at Institut Pasteur, priced at €50 for medical interns.
Quantifiable outcome
- LAbyrInth detected inner ear anomalies at risk of developing hydrops that are invisible to radiologists with the naked eye, enabling earlier intervention before irreversible cochlear damage in Ménière's disease patients
- +2 more outcomes
Companies that use GeodAIsics
Customer profileNamed customers4 records
Segments4 records
Ideal customer profiles2 records
GeodAIsics technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration1 record
AI capability8 records
Feature10 records
GeodAIsics partnerships and signals
Strategic signalPartnerships
21 partnerships are on record, tiered core and minor.
- HORIBAcoreGeodAIsics and HORIBA announced a partnership in September 2025 to develop an AI-powered sepsis detection solution. This represents a significant strategic alliance between GeodAIsics' generative AI technology and HORIBA's diagnostic systems capabilities.
- Les Biologistes Indépendants (LBI)coreLes Biologistes Indépendants entered the capital of GeodAIsics as a strategic alliance to strengthen preventive medical biology reinforced by artificial intelligence. This investment represents both a financial and strategic partnership in the medical biology sector.
- BYG4labcoreBYG4lab signed a partnership agreement with GeodAIsics to strengthen Ynfectio, their epidemiology and infection control software, with an AI module. The collaboration enabled quick and efficient AI integration into BYG4lab's existing software, bringing respective expertise to achieve tangible results.
- BayercoreGeodAIsics partnered with Bayer for a November 2022 webinar targeting radiologists on the topic of 'Dementia and AI'. Bayer is a major pharmaceutical and life sciences company, and this partnership helped position GeodAIsics' DementIA software within the radiology community.
- Institut PasteurcoreInstitut Pasteur is GeodAIsics' academic partner for training and education. The September 2025 training session on biological Alzheimer diagnosis takes place at the Institut de l'Audition, part of Institut Pasteur. The partnership supports academic-level medical training combining neuroimaging and AI.
- AP-HP (Assistance Publique - Hôpitaux de Paris)minorListed as a partner on GeodAIsics' validations page. AP-HP is France's largest hospital system and represents a key reference institution for clinical validation of GeodAIsics' technology.
- HCL (Hospices Civils de Lyon)minorListed as a partner on GeodAIsics' validations page. HCL is a major university hospital system in Lyon, France, involved in clinical validation of GeodAIsics' solutions.
- CHU Grenoble AlpesminorListed as a partner on GeodAIsics' validations page. CHU Grenoble is a key academic hospital partner for GeodAIsics, given the co-founders' ties to the Grenoble region.
- CHU BrestminorListed as a partner on GeodAIsics' validations page.
- CHU RouenminorListed as a partner on GeodAIsics' validations page.
- CHU NiceminorListed as a partner on GeodAIsics' validations page.
- Centre Léon BérardminorListed as a partner on GeodAIsics' validations page. Centre Léon Bérard is a comprehensive cancer center in Lyon, relevant to OncoGML product validation.
- Fondation RothschildminorListed as a partner on GeodAIsics' validations page.
- Université de Sydney (The University of Sydney)minorListed as a partner on GeodAIsics' validations page. International academic partnership for research collaboration.
- AlexionminorListed as a partner on GeodAIsics' validations page. Alexion is a pharmaceutical/biotechnology company (part of AstraZeneca), potentially a customer or research collaborator.
- BraccominorListed as a partner on GeodAIsics' validations page. Bracco is a pharmaceutical company specializing in diagnostic imaging, relevant to GeodAIsics' imaging-based AI solutions.
- MedicalPSminorListed as a partner on GeodAIsics' validations page. MedicalPS is a competitiveness cluster for medical technologies in the Grenoble area, supporting medtech innovation.
- Lyon BiopoleminorListed as a partner on GeodAIsics' validations page. Lyon Biopole is a competitiveness cluster supporting companies in health industries and biotechnology in the Auvergne-Rhône-Alpes region.
- MinalogicminorListed as a partner on GeodAIsics' validations page. Minalogic is a competitiveness cluster for digital technologies including AI and microelectronics in the Grenoble area.
- BioAmiensminorListed as a partner on GeodAIsics' validations page.
- Lille ClimalminorListed as a partner on GeodAIsics' validations page.
Scale indicators3 records
Recent moves6 records
Expansion highlights7 records
GeodAIsics competitors and assessment
Company assessmentBroad incumbents
- Owkin: French AI-for-health company using federated learning across hospitals for drug discovery, diagnostics, and clinical research. Comparable in French AI-health positioning and serving pharma/CRO customers like GeodAIsics' custom software business, though much larger and broader in scope.
- Siemens Healthineers (AI-Rad Companion): Major medical imaging and diagnostics vendor offering AI-Rad Companion for AI-augmented radiology and digital health platforms. Indirectly comparable as a broad incumbent that bundles AI radiology capabilities into its installed imaging base, putting competitive pressure on GeodAIsics' imaging AI modules.
Direct peers
- Gleamer: French AI radiology company with CE-marked products for bone, chest, and mammography interpretation. Direct peer in geography (France), regulatory pathway (CE marking), and AI-driven radiology decision support for healthcare institutions.
- Therapixel: French AI company developing MammoScreen 2.x for breast cancer screening using deep learning on mammograms. Comparable to GeodAIsics' OncoGML in applying AI to breast cancer imaging, with CE marking and European commercial focus.
- Viz.ai: Specializes in AI-based clinical decision support for neuroimaging, most notably for stroke detection and triage. Comparable to GeodAIsics' BrainGML in focusing on AI over brain imaging and care coordination for time-sensitive neurological conditions.
- Arterys: Cloud-native AI platform for medical imaging with FDA-cleared modules for cardiac and lung MRI/CT. Comparable to GeodAIsics as a clinical imaging AI platform with multiple specialty modules and a SaaS delivery model to healthcare institutions.
- Qure.ai: AI medical imaging company with multiple CE-marked and FDA-cleared products for chest X-ray, head CT, and tuberculosis triage. Comparable to GeodAIsics' clinical decision support suite across multiple imaging modalities, though focused on Deep Learning.
- Pixyl: French AI company focused on neuroimaging analysis, particularly for multiple sclerosis and other neurological conditions. Closely comparable to GeodAIsics' BrainGML on neuroimaging AI and is another French medtech using AI to support radiologists and neurologists.
- Aidoc: AI-powered clinical decision support for medical imaging (CT, MRI, X-ray), with multiple FDA-cleared modules for radiology workflows. Directly comparable to GeodAIsics' AI-driven imaging decision support products, though Aidoc focuses on Deep Learning and emergency/acute care rather than manifold learning.
Emerging players
- Annalise.ai: AI clinical decision support for radiology covering 100+ findings on chest X-ray and CT. Comparable as a multi-module AI decision support suite aimed at radiologists, with overlapping scope to GeodAIsics' BrainGML and OtoGML in creating structured AI assistance for image interpretation.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
GeodAIsics social profiles
Digital presenceGeodAIsics financial estimates
Financial estimateRevenue estimate
Valuation estimate
GeodAIsics leadership team
Management profileNumber of profiles
Profiles15 records
GeodAIsics funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
GeodAIsics M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about GeodAIsics
What does GeodAIsics do?
GeodAIsics develops and licenses proprietary clinical decision support software for medical imaging and biological analysis, powered by its patented Generative Manifold Learning (GML) AI technology. Core products include BrainGML (brain MRI analysis for Alzheimer's, Parkinson's, FTD), OncoGML (cancer prognosis), BioGML (blood sample validation), OtoGML and LAbyrInth (inner ear anomaly detection), plus DementIA for dementia differentiation. The company also offers custom software development and paid training workshops for healthcare professionals.
Is GeodAIsics a public or private company?
GeodAIsics is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was GeodAIsics founded?
GeodAIsics was founded in 2021. It employs 1 to 10 people.
Where is GeodAIsics based?
GeodAIsics is headquartered in La Tronche, France, in the Europe region.
How does GeodAIsics make money?
Three revenue lines are on record. Proprietary Software Licenses are the primary driver. The others are custom Software Development and professional Training and Workshops.
Who are GeodAIsics's main competitors?
Broad incumbents on record are Owkin and Siemens Healthineers (AI-Rad Companion). Direct peers are Gleamer, Therapixel, Viz.ai, Arterys, Qure.ai, Pixyl and Aidoc. Annalise.ai is listed as an emerging player.
Does GeodAIsics have an API?
No public API is recorded for GeodAIsics.
What industry is GeodAIsics in?
GeodAIsics's product category is Clinical Decision Support Software. Its primary akta.pro industry code is HLACANAG, SaMD – Imaging & Signal Analysis (AI/ML), with a secondary code of HLAHABAJ, Radiology AI, CAD & Advanced Visualization Software. Its NAICS code is 5417 and its SIC code is 3841.